Follow
James Rickard
James Rickard
Royal Melbourne Hospital
Verified email at mh.org.au
Title
Cited by
Cited by
Year
Linear ubiquitination prevents inflammation and regulates immune signalling
B Gerlach, SM Cordier, AC Schmukle, CH Emmerich, E Rieser, TL Haas, ...
Nature 471 (7340), 591-596, 2011
9702011
RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis
JA Rickard, JA O’Donnell, JM Evans, N Lalaoui, AR Poh, TW Rogers, ...
Cell 157 (5), 1175-1188, 2014
5882014
The diverse role of RIP kinases in necroptosis and inflammation
J Silke, JA Rickard, M Gerlic
Nature immunology 16 (7), 689-697, 2015
4902015
The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity
RB Damgaard, U Nachbur, M Yabal, WWL Wong, BK Fiil, M Kastirr, ...
Molecular cell 46 (6), 746-758, 2012
4052012
TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice
JA Rickard, H Anderton, N Etemadi, U Nachbur, M Darding, N Peltzer, ...
Elife 3, e03464, 2014
2552014
LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis
N Peltzer, M Darding, A Montinaro, P Draber, H Draberova, S Kupka, ...
Nature 557 (7703), 112-117, 2018
1742018
In TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-κB and activation of caspase-8
IE Gentle, WWL Wong, JM Evans, A Bankovacki, WD Cook, NR Khan, ...
Journal of Biological Chemistry 286 (15), 13282-13291, 2011
1012011
TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1
N Etemadi, M Chopin, H Anderton, MC Tanzer, JA Rickard, W Abeysekera, ...
elife 4, e10592, 2015
952015
A missense mutation in the MLKL brace region promotes lethal neonatal inflammation and hematopoietic dysfunction
JM Hildebrand, M Kauppi, IJ Majewski, Z Liu, AJ Cox, S Miyake, EJ Petrie, ...
Nature communications 11 (1), 3150, 2020
702020
RIPK1 prevents TRADD-driven, but TNFR1 independent, apoptosis during development
H Anderton, E Bandala-Sanchez, DS Simpson, JA Rickard, AP Ng, ...
Cell Death & Differentiation 26 (5), 877-889, 2019
542019
Combination of IAP antagonist and IFNγ activates novel caspase-10-and RIPK1-dependent cell death pathways
MC Tanzer, N Khan, JA Rickard, N Etemadi, N Lalaoui, SK Spall, ...
Cell Death & Differentiation 24 (3), 481-491, 2017
522017
Inhibitor of apoptosis proteins (IAPs) limit RIPK1-mediated skin inflammation
H Anderton, JA Rickard, GA Varigos, N Lalaoui, J Silke
Journal of Investigative Dermatology 137 (11), 2371-2379, 2017
342017
Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease
A Vasudevan, N Parthasarathy, D Con, S Nicolaides, R Apostolov, ...
Alimentary Pharmacology & Therapeutics 52 (7), 1174-1184, 2020
212020
Screening and prophylaxis to prevent hepatitis b reactivation: transplant recipients
J Sasadeusz, A Grigg, PD Hughes, SL Lim, M Lucas, G McColl, ...
Clinics in liver disease 23 (3), 493-509, 2019
12*2019
Erratum: the diverse role of RIP kinases in necroptosis and inflammation
J Silke, JA Rickard, M Gerlic
Nature immunology 16 (8), 889-889, 2015
112015
Sharpin is a key regulator of skeletal homeostasis in a TNF-dependent manner
H McGowan, J Schuijers, B Grills, S McDonald, JA Rickard, J Silke, ...
La Trobe, 2014
72014
Correction: TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1
N Etemadi, M Chopin, H Anderton, MC Tanzer, JA Rickard, W Abeysekera, ...
Elife 6, e29849, 2017
62017
Dual roles for LUBAC signaling in thymic epithelial cell development and survival
R Jain, K Zhao, JM Sheridan, M Heinlein, F Kupresanin, W Abeysekera, ...
Cell Death & Differentiation 28 (10), 2946-2956, 2021
52021
Development of a simple, serum biomarker-based model predictive of the need for early biologic therapy in Crohn’s disease
D Con, N Parthasarathy, M Bishara, RP Luber, N Joshi, A Wan, ...
Journal of Crohn's and Colitis 15 (4), 583-593, 2021
52021
Screening and prophylaxis to prevent hepatitis B reactivation: patients with hematological and solid tumor malignancies
J Sasadeusz, A Grigg, PD Hughes, SL Lim, M Lucas, G McColl, ...
Clinics in liver disease 23 (3), 511-519, 2019
52019
The system can't perform the operation now. Try again later.
Articles 1–20